PIERRE FABRE LIMITED: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyMain market: Pharmaceutical products

Official UK PPONPRHQ-6453-ZCGDCompanies House00986738 ↗ · Active

Where they win
i

15 awards (15 for a named lot, 100%, 0 for a whole procedure with no lot named) · top CPV classes, shares of all 15 awards. An award may cover more than one class.

3360 Pharmaceutical products10 awards · 67% · awards naming a lot
Attributable award value
i
£5.2mOn 9 of 15 award records; the five largest make 83%. Largest rows below.
Typical attributable award
i
£500k middle valuerobust · n=9

Where their buyers are
i

ITL1 region of the buyer office · known for 17 of 17 awarded procedures · each procedure counts once

Northern Ireland9 procedures · 53%
Greater London4 procedures · 24%
South East England2 procedures · 12%
North West England1 procedure · 6%
Scotland1 procedure · 6%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 2 notices name this supplier since 26 Feb 2026 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
1 of 2
Authorities bid for
i
1
NoticeAuthorityOutcomeBiddersPublished
NHS National Generic Pharmaceuticals - Wave 16aframework/DPSNHS Englandappointed1259 Oct 2026
NHS National Generic Pharmaceuticals - Wave 15cframework/DPSNHS Englandnot appointed11826 Feb 2026

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health100%(15 awards)
    15 of 15 awards are NHS & health (100%).
AuthorityProceduresShareAward recordsLast activity
Belfast Health & Social Care Trust741.2%717 Apr 2026
NHS Englandframework/DPS on 4423.5%427 Aug 2026
Northern Health and Social Care Trust211.8%217 Aug 2026
ATAMIS LTD211.8%230 Nov 2021
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 115.9%130 Nov 2021
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 115.9%19 Jun 2021

Share = of the 17 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

10 of 17 awards carry an end date, 3 estimated from the duration · not a retender forecast

ContractEndsPublished value
Wave 15a - Hospital Only Products (DNW & DLN regions)31 Jan 2027£1 ceiling
Wave 15b - Hospital Only DCE & DSW regions30 Sept 2027£1 ceiling
BINIMETINIB 45MG 28PK31 Mar 2028£420,000

Recent awards

Latest 15 of 15 award records naming this supplier

Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regionsNHS England27 Aug 2026£393,331,872
framework ceiling · 1 of 101 appointed suppliers
ENCORAFENIB (BRAFTOVI) 75 mg CapsulesNorthern Health and Social Care Trust17 Aug 2026£180,000
BINIMETINIB 45MG 28PKBelfast Health & Social Care Trust17 Apr 2026£420,000
ENCORAFENIB 75 mg Hard Capsules 42 Capsule PackBelfast Health & Social Care Trust9 Jun 2025£1,200,000
Wave 15b - Hospital Only DCE & DSW regionsNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NERATINIB 40 mg Tablets 180 Tablet PackBelfast Health & Social Care TrustNot published£122,000 †
from the contract notice
Wave 15a - Hospital Only Products (DNW & DLN regions)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Contract for ENCORAFENIB (BRAFTOVI) 75mg CapsulesNorthern Health and Social Care TrustNot published£162,120 †
from the contract notice
ENCORAFENIB 75 mg Hard Capsules 42 Capsule PackBelfast Health & Social Care TrustNot published£900,000 †
from the contract notice
Lot 1 - CM/PHG/22/5657/02 Hospital Only Products: DLN & DNW:NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 7 of 17 awards, estimated from the published duration on 3 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.